ICPT logo

ICPT Total Liabilities

ICPT Annual Total Liabilities

$460.63 M
-$250.35 M-35.21%

31 December 2022

ICPT Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Quarterly Total Liabilities

$321.32 M
-$95.77 M-22.96%

30 September 2023

ICPT Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-35.2%-28.9%
3 y3 years-34.5%-55.5%
5 y5 years-1.6%-30.3%

ICPT Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-38.4%-63.3%

Intercept Pharmaceuticals Total Liabilities History

DateAnnualQuarterly
Sept 2023
-
$321.32 M(-23.0%)
June 2023
-
$417.09 M(-4.5%)
Mar 2023
-
$436.90 M(-5.2%)
Dec 2022
$460.63 M(-35.2%)
$460.63 M(+2.0%)
Sept 2022
-
$451.73 M(-48.0%)
June 2022
-
$868.43 M(-0.8%)
Mar 2022
-
$875.12 M(+23.1%)
Dec 2021
$710.99 M(-4.9%)
$710.99 M(+4.7%)
Sept 2021
-
$679.10 M(-6.5%)
June 2021
-
$726.42 M(+0.9%)
Mar 2021
-
$720.11 M(-3.6%)
Dec 2020
$747.34 M(+6.3%)
$747.34 M(+3.6%)
Sept 2020
-
$721.64 M(+0.7%)
June 2020
-
$716.29 M(+2.8%)
Mar 2020
-
$697.10 M(-0.9%)
Dec 2019
$703.33 M(+43.5%)
$703.33 M(+4.8%)
Sept 2019
-
$671.36 M(-0.9%)
June 2019
-
$677.77 M(+37.4%)
Mar 2019
-
$493.26 M(+0.7%)
Dec 2018
$490.04 M(+4.7%)
$490.04 M(+6.3%)
Sept 2018
-
$461.14 M(+0.6%)
June 2018
-
$458.34 M(+2.7%)
Mar 2018
-
$446.09 M(-4.7%)
DateAnnualQuarterly
Dec 2017
$467.96 M(+10.3%)
$467.96 M(+4.3%)
Sept 2017
-
$448.76 M(+0.6%)
June 2017
-
$446.04 M(+4.3%)
Mar 2017
-
$427.78 M(+0.8%)
Dec 2016
$424.32 M(+691.5%)
$424.32 M(+6.8%)
Sept 2016
-
$397.32 M(+269.6%)
June 2016
-
$107.50 M(+2.3%)
Mar 2016
-
$105.04 M(+95.9%)
Dec 2015
$53.61 M(+130.5%)
$53.61 M(+37.9%)
Sept 2015
-
$38.86 M(+25.7%)
June 2015
-
$30.91 M(+20.2%)
Mar 2015
-
$25.72 M(+10.6%)
Dec 2014
$23.26 M(-65.8%)
$23.26 M(-6.8%)
Sept 2014
-
$24.96 M(+19.8%)
June 2014
-
$20.83 M(-93.0%)
Mar 2014
-
$295.64 M(+335.3%)
Dec 2013
$67.91 M(+46.8%)
$67.91 M(-0.0%)
Sept 2013
-
$67.93 M(+42.7%)
June 2013
-
$47.60 M(+4.8%)
Mar 2013
-
$45.40 M(-1.9%)
Dec 2012
$46.27 M(+110.0%)
$46.27 M(+101.8%)
Sept 2012
-
$22.93 M(+4.5%)
June 2012
-
$21.95 M(-0.4%)
Dec 2011
$22.03 M
$22.03 M

FAQ

  • What is Intercept Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals annual total liabilities year-on-year change?
  • What is Intercept Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals quarterly total liabilities year-on-year change?

What is Intercept Pharmaceuticals annual total liabilities?

The current annual total liabilities of ICPT is $460.63 M

What is the all time high annual total liabilities for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high annual total liabilities is $747.34 M

What is Intercept Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, ICPT annual total liabilities has changed by -$250.35 M (-35.21%)

What is Intercept Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of ICPT is $321.32 M

What is the all time high quarterly total liabilities for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high quarterly total liabilities is $875.12 M

What is Intercept Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, ICPT quarterly total liabilities has changed by -$130.41 M (-28.87%)